Secondary Glaucoma (Pseudoexfoliation) Medication Savings with TheDrugClub
Members can check active-formulary eligibility and membership pricing for Secondary Glaucoma (Pseudoexfoliation) medications. A condition association alone does not establish coverage.
What Is Secondary Glaucoma (Pseudoexfoliation)?
Secondary Glaucoma (Pseudoexfoliation) is a medical condition that may require prescription treatment. Consult a healthcare professional about appropriate options.
Managing Secondary Glaucoma (Pseudoexfoliation) with TheDrugClub
Eligible medications linked to the active formulary may have no additional cost under listed supply, quantity, fill, and fulfillment limits. Other prescriptions may qualify for membership pricing. Confirm current terms before filling.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available membership pricing
About Secondary Glaucoma (Pseudoexfoliation)
Secondary glaucoma pseudoexfoliation is a serious eye condition where abnormal protein deposits affect fluid drainage, leading to increased eye pressure and potential vision loss. Managing it requires ongoing medication to preserve sight. TheDrugClub helps make these essential prescriptions more affordable for our members, ensuring continuous access to critical care without overwhelming financial strain.
Secondary glaucoma pseudoexfoliation (PEXG) is a specific type of open-angle glaucoma characterized by the accumulation of a flaky, whitish material (pseudoexfoliative material) throughout the front part of the eye. This abnormal protein deposit, often resembling dandruff, can collect in the drainage system of the eye, known as the trabecular meshwork. Over time, this blockage obstructs the natural outflow of aqueous humor (the fluid inside the eye), leading to a buildup of intraocular pressure (IOP). Elevated IOP is the primary risk factor for damage to the optic nerve, which can result in irreversible vision loss and blindness if left untreated.
PEXG is more prevalent in older individuals and has a higher incidence in certain populations, particularly those of Scandinavian descent. While many people with pseudoexfoliation syndrome may not develop glaucoma, they are at a significantly higher risk and require regular monitoring. Early stages often present without noticeable symptoms, making routine eye exams crucial for detection. Diagnosis typically involves a thorough eye examination, including measuring IOP, inspecting the optic nerve, and examining the drainage angle for the characteristic pseudoexfoliative material.
Treatment for PEXG primarily focuses on lowering intraocular pressure to prevent further optic nerve damage. This often begins with prescription eye drops. Common medications include prostaglandin analogs (e.g., latanoprost, travoprost), beta-blockers (e.g., timolol), alpha-agonists (e.g., brimonidine), and carbonic anhydrase inhibitors (e.g., dorzolamide). These drops work in various ways
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.